Listed

Aveanna Healthcare Holdings, Inc.

AVAHNasdaqCIK 1832332HealthcareFiscal year ends Jan 1

Latest reported revenue, Q2 FY2026$670.5mRevenue, Q2 FY2026, three months to 2026-07-04$670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figureThree months to Jul 4, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jul 4, 2026, against the same quarter a year earlier.

  • Revenue$670.5mRevenue, Q2 FY2026, three months to 2026-07-04$670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure+13.7% on a year earlier
  • Gross margin32.6%Gross margin, Q2 FY2026, three months to 2026-07-04. gross profit / revenueGross profit: $218.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure−3.2 pts on a year earlier
  • Operating margin11.9%Operating margin, Q2 FY2026, three months to 2026-07-04. operating income / revenueOperating income: $80.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure−1.6 pts on a year earlier
  • Net margin6.0%Net margin, Q2 FY2026, three months to 2026-07-04. net income / revenueNet income: $40.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure+1.4 pts on a year earlier
  • Diluted EPS$0.18Diluted EPS, Q2 FY2026, three months to 2026-07-04$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure+38.5% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$670.5mGross margin 32.6%
Diluted EPS$0.18, Q2 FY2026
Aveanna Healthcare Holdings, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04Shape over the periods
Revenue$m509Revenue, Q3 FY2024, three months to 2024-09-28$509.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure520Revenue, Q4 FY2024, three months to 2024-12-28$519.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure559Revenue, Q1 FY2025, three months to 2025-03-29$559.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure590Revenue, Q2 FY2025, three months to 2025-06-28$589.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure622Revenue, Q3 FY2025, three months to 2025-09-27$621.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure662Revenue, Q4 FY2025, three months to 2026-01-03$662.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure648Revenue, Q1 FY2026, three months to 2026-04-04$647.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure670Revenue, Q2 FY2026, three months to 2026-07-04$670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure
Gross margin%31.4%Gross margin, Q3 FY2024, three months to 2024-09-28. gross profit / revenueGross profit: $159.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $509.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure33.0%Gross margin, Q4 FY2024, three months to 2024-12-28. gross profit / revenueGross profit: $171.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $519.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure32.8%Gross margin, Q1 FY2025, three months to 2025-03-29. gross profit / revenueGross profit: $183.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $559.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure35.8%Gross margin, Q2 FY2025, three months to 2025-06-28. gross profit / revenueGross profit: $210.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $589.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure32.6%Gross margin, Q3 FY2025, three months to 2025-09-27. gross profit / revenueGross profit: $202.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $621.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure32.2%Gross margin, Q4 FY2025, three months to 2026-01-03. gross profit / revenueGross profit: $213.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $662.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure31.7%Gross margin, Q1 FY2026, three months to 2026-04-04. gross profit / revenueGross profit: $205.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $647.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure32.6%Gross margin, Q2 FY2026, three months to 2026-07-04. gross profit / revenueGross profit: $218.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure
Operating margin%6.7%Operating margin, Q3 FY2024, three months to 2024-09-28. operating income / revenueOperating income: $34.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $509.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure8.8%Operating margin, Q4 FY2024, three months to 2024-12-28. operating income / revenueOperating income: $45.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $519.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure9.3%Operating margin, Q1 FY2025, three months to 2025-03-29. operating income / revenueOperating income: $51.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $559.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure13.6%Operating margin, Q2 FY2025, three months to 2025-06-28. operating income / revenueOperating income: $80.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $589.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure8.6%Operating margin, Q3 FY2025, three months to 2025-09-27. operating income / revenueOperating income: $53.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $621.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure10.7%Operating margin, Q4 FY2025, three months to 2026-01-03. operating income / revenueOperating income: $71.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $662.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure10.7%Operating margin, Q1 FY2026, three months to 2026-04-04. operating income / revenueOperating income: $69.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $647.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure11.9%Operating margin, Q2 FY2026, three months to 2026-07-04. operating income / revenueOperating income: $80.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure
Net margin%(8.4%)Net margin, Q3 FY2024, three months to 2024-09-28. net income / revenueNet income: −$42.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $509.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure5.6%Net margin, Q4 FY2024, three months to 2024-12-28. net income / revenueNet income: $29.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $519.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure0.9%Net margin, Q1 FY2025, three months to 2025-03-29. net income / revenueNet income: $5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $559.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure4.6%Net margin, Q2 FY2025, three months to 2025-06-28. net income / revenueNet income: $27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $589.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure2.3%Net margin, Q3 FY2025, three months to 2025-09-27. net income / revenueNet income: $14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Revenue: $621.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figure27.0%Net margin, Q4 FY2025, three months to 2026-01-03. net income / revenueNet income: $178.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Revenue: $662.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851. Derived: 12-month figure less the 9-month figure.Report this figure6.4%Net margin, Q1 FY2026, three months to 2026-04-04. net income / revenueNet income: $41.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Revenue: $647.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure6.0%Net margin, Q2 FY2026, three months to 2026-07-04. net income / revenueNet income: $40.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Revenue: $670.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure
Diluted EPS$ per share(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-28−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figurenot reported (Diluted EPS not reported)0.03Diluted EPS, Q1 FY2025, three months to 2025-03-29$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure0.13Diluted EPS, Q2 FY2025, three months to 2025-06-28$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure0.06Diluted EPS, Q3 FY2025, three months to 2025-09-27$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-267978.Report this figurenot reported (Diluted EPS not reported)0.19Diluted EPS, Q1 FY2026, three months to 2026-04-04$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222736.Report this figure0.18Diluted EPS, Q2 FY2026, three months to 2026-07-04$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347842.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$2.43bnGross margin 33.3%
Diluted EPS$1.05, FY2025
Free cash flow−$27.3m, FY2021
Aveanna Healthcare Holdings, Inc., key figures for the last five fiscal years
Line itemUnitFY20212022-01-01FY20222022-12-31FY20232023-12-30FY20242024-12-28FY20252026-01-03Shape over the periods
Revenue$m1,679Revenue, FY2021, twelve months to 2022-01-01$1.68bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-16, accession 0000950170-23-008309.Report this figure1,788Revenue, FY2022, twelve months to 2022-12-31$1.79bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-14, accession 0000950170-24-031321.Report this figure1,895Revenue, FY2023, twelve months to 2023-12-30$1.90bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038504.Report this figure2,025Revenue, FY2024, twelve months to 2024-12-28$2.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure2,433Revenue, FY2025, twelve months to 2026-01-03$2.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure
Gross margin%32.3%Gross margin, FY2021, twelve months to 2022-01-01. gross profit / revenueGross profit: $542.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-16, accession 0000950170-23-008309.Revenue: $1.68bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-16, accession 0000950170-23-008309.Report this figure30.9%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $553.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-14, accession 0000950170-24-031321.Revenue: $1.79bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-14, accession 0000950170-24-031321.Report this figure31.4%Gross margin, FY2023, twelve months to 2023-12-30. gross profit / revenueGross profit: $595.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-13, accession 0000950170-25-038504.Revenue: $1.90bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038504.Report this figure31.4%Gross margin, FY2024, twelve months to 2024-12-28. gross profit / revenueGross profit: $635.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure33.3%Gross margin, FY2025, twelve months to 2026-01-03. gross profit / revenueGross profit: $810.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure
Operating margin%(2.2%)Operating margin, FY2021, twelve months to 2022-01-01. operating income / revenueOperating income: −$36.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-16, accession 0000950170-23-008309.Revenue: $1.68bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-16, accession 0000950170-23-008309.Report this figure(35.9%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$642.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-14, accession 0000950170-24-031321.Revenue: $1.79bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-14, accession 0000950170-24-031321.Report this figure0.4%Operating margin, FY2023, twelve months to 2023-12-30. operating income / revenueOperating income: $8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038504.Revenue: $1.90bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038504.Report this figure6.9%Operating margin, FY2024, twelve months to 2024-12-28. operating income / revenueOperating income: $139.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure10.5%Operating margin, FY2025, twelve months to 2026-01-03. operating income / revenueOperating income: $256.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure
Net margin%(7.0%)Net margin, FY2021, twelve months to 2022-01-01. net income / revenueNet income: −$117.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-16, accession 0000950170-23-008309.Revenue: $1.68bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-16, accession 0000950170-23-008309.Report this figure(37.0%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$662.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-14, accession 0000950170-24-031321.Revenue: $1.79bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-14, accession 0000950170-24-031321.Report this figure(7.1%)Net margin, FY2023, twelve months to 2023-12-30. net income / revenueNet income: −$134.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038504.Revenue: $1.90bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038504.Report this figure(0.5%)Net margin, FY2024, twelve months to 2024-12-28. net income / revenueNet income: −$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure9.2%Net margin, FY2025, twelve months to 2026-01-03. net income / revenueNet income: $225.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115851.Revenue: $2.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure
Diluted EPS$ per share(0.69)Diluted EPS, FY2021, twelve months to 2022-01-01−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-16, accession 0000950170-23-008309.Report this figure(3.57)Diluted EPS, FY2022, twelve months to 2022-12-31−$3.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-14, accession 0000950170-24-031321.Report this figure(0.71)Diluted EPS, FY2023, twelve months to 2023-12-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-13, accession 0000950170-25-038504.Report this figure(0.06)Diluted EPS, FY2024, twelve months to 2024-12-28−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure1.05Diluted EPS, FY2025, twelve months to 2026-01-03$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-19, accession 0001193125-26-115851.Report this figure
Free cash flow$m(27.3)Free cash flow, FY2021, twelve months to 2022-01-01. operating cash flow − capital expenditureOperating cash flow: −$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-16, accession 0000950170-23-008309.Capital expenditure: $15.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-03-28, accession 0000950170-22-004799.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Aveanna Healthcare Holdings, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Bain Capital Investors LLC2026-06-30$699.3m81,600,880Unchanged
J.H. Whitney Equity Partners VII, LLC2026-06-30$231.9m27,061,967Reduced−9,180,664
Nut Tree Capital Management, LP2026-06-30$110.7m12,922,649Unchanged
BlackRock, Inc.2026-06-30$63.5m7,410,053Added+1,909,141
Ophir Asset Management Pty Ltd2026-06-30$43.7m5,100,000New+5,100,000
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$31.5m3,673,218Reduced−301,601
BRAIDWELL LP2026-06-30$26.3m3,065,106Added+861,600
Boston Partners2026-06-30$24.9m2,870,979Added+46,905
CITADEL ADVISORS LLC2026-06-30$19.6m2,285,756Added+2,008,806
DIMENSIONAL FUND ADVISORS LP2026-06-30$19.3m2,257,684Added+923,310

Recent filings

All 411 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Aveanna Healthcare Holdings, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-0220:55 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-412540
2026-08-2420:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-363654
2026-08-1311:00 ET10-QQuarterly reportPeriod 2026-07-040001193125-26-347842
2026-08-1311:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-347840
2026-08-1311:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-347839
2026-08-0720:43 ET8-K5.02 Departure or appointment of officers or directors0001193125-26-340409
2026-06-0211:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-252511
2026-05-2920:15 ET8-K5.07 Shareholder vote results0001193125-26-248323
2026-05-2812:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-243028
2026-05-1512:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-225430

Latest annual report

Form 10-K for the fiscal year ended Jan 3, 2026Filed Mar 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1832332
Tickers
AVAH
Exchange
Nasdaq
SIC code
8082 Services-Home Health Care Services
Sector
Healthcare
Fiscal year ends
Jan 1
Incorporated in
DE
Filer category
Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.